Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
NY Support Lags for Sickle-Cell Patients Facing Pain, Poor Treatment, Discrimination
Chronic pain, health complications and frequent trips to the emergency room are everyday concerns for an estimated 10,000 New Yorkers living with sickle-cell disease.
Together, these individuals account for 10 percent of the country’s population diagnosed with the inherited blood disorder. Despite this geographic concentration, patients, advocates and health providers say that funding and overall quality of care continues to fall short in New York State.
In 2017, the state allocated $250,000 to sickle-cell in its annual budget. Legislation to boost that funding has been introduced in both the New York State Assembly and Senate, asking for a budget of $3 million.
+myBinderRelated Content
-
Hand Foot Syndrome in Sickle Cell AnemiaHand Foot Syndrome in Sickle Cell Anemia...
-
Healthcare Providers and Sickle Cell DiseaseSickle cell disease (SCD) is a group of ...
-
Children’s MinnesotaChildren’s Cancer and Blood Disorders ...
-
Capitol Hill Briefing Held to Encourage Sickle Cell Research and TreatmentEarlier today, a briefing was hosted on ...
-
CIRM and NHLBI Collaborating to Fund Cell and Gene Therapies for Sickle Cell DiseaseThe California Institute for Regenerativ...
-
2016 Annual Sickle Cell Disease Clinical Research MeetingsThe NHLBI Annual Sickle Cell Disease Cli...
-
University of Pittsburgh Medical CenterPeople with inherited blood disorders re...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
